Vasogen Inc. INVESTOR CONTACT
2155 Dunwin Drive
Mississauga, ON, Canada L5L 4M1 Glenn Neumann
tel: (905) 569-2265 fax: (905) 569-9231 Investor Relations
www.vasogen.com (905) 569-9065
[email protected]
--------------------------------------------------------------------------------
FOR IMMEDIATE RELEASE
Vasogen to Conduct Quarterly Conference Call
Toronto, Ontario (January 19, 2001) -- Vasogen Inc. (TSE:VAS; AMEX:MEW) will
conduct its quarterly conference call on Tuesday, January 23, 2001 at 4:10 p.m.
Eastern Time to provide a regular quarterly update on corporate developments.
The conference will also be available via audio webcast. Participants are
invited to attend by connecting 10 minutes prior to the call to one of the
following:
----------------------------------------------
Direct Dial 416-640-4127
----------------------------------------------
Toll-free 888-881-4892
----------------------------------------------
Audio Webcast* www.vasogen.com
----------------------------------------------
*RealPlayer required
The conference call will be re-broadcast until January 30, 2001 and may be
accessed by calling:
------------------------------------------------------------------
Direct Dial 416-640-1917 Passcode: 88923#
------------------------------------------------------------------
The audio webcast will also be available for replay via Vasogen's website at
www.vasogen.com.
Vasogen is focused on developing immune modulation therapies to advance the
treatment of cardiovascular, autoimmune and related inflammatory diseases.
These therapies are designed to target fundamental disease-causing events,
providing safe, effective treatment.
Statements contained in this press release, and in the upcoming conference call,
including those pertaining to scientific and clinical research,
commercialization plans, strategic alliances, and intellectual property
protection, other than statements of historical fact, are forward-looking
statements subject to a number of uncertainties that could cause actual results
to differ materially from statements made.
